The University of Cambridge said the Trinity Cambridge Research Studentships (TCRS) have been created to respond to declining ...

Trinity College and the University of Cambridge will provide £48 million over 5 years to fund around 30 PhD students ...

【导读】针对肿瘤特异性新抗原的免疫治疗具有潜力，但它们在肿瘤细胞上的超低表达，对T细胞治疗提出了挑战。在这项研究中，团队发现，嵌合抗原受体（CARs）在针对人类白细胞抗原（HLA）I类呈现的p53R175H新抗原时，其敏感性比T细胞受体（TCRs）低 ...

Nobel laureate Dr Venki Ramakrishnan supports a new £48 million programme by Trinity College and the University of Cambridge to offer fully funded PhDs. The initiative aims to attract top talent ...

Planegg/Martinsried, November 11, 2024. Medigene AG (Medigene or the“Company”, FSE: MDG1, Prime Standard), an oncology <a target=_blank h ...

Members of Medigene management as expert speakers, Prof. Dolores Schendel, Chief Scientific Officer and Kirsty Crame, MD, Vice President, Clinical Strategy & Development Presentations and seminars ...

MDG1015 received IND approval in Q3 2024 and is on track for CTA filing in Q4 2024. Prof. Dolores Schendel presented the “TCR-T Platform for Solid Tumors” covering Medigene’s End-to-End Platform ...

Immunocore is a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease ...

PRAME-TCR iNKT Represents a Promising Targeted Therapy for Refractory Solid Tumors: iNKT cells present an ideal platform for tumor-targeting T cell receptor expression due to the absence of ...

Goldfinch Cyclery's 8th Annual Cranksgiving bike ride and food drive will be held November 10th at 11am starting at Newbo ...

Stock markets in the UK and across Europe faltered on Wednesday afternoon while Wall Street soared in reaction to Donald ...